Intranasal route is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-10-20. Numbers and descriptions here follow the published literature rather than marketing material.
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Laboratory work relies on standard behavioral paradigms. Rodents are tested in the elevated plus maze, open field, and passive avoidance tasks, with outcomes compared against diazepam or vehicle controls. Intranasal dosing is used most often because it bypasses first-pass metabolism, though intraperitoneal and intravenous routes also appear in published protocols. Biochemical endpoints include tissue BDNF concentrations, cytokine levels, and monoamine metabolites. Human data are limited to small Russian trials reporting reduced anxiety scores; most were not prospectively registered, and few employed independent outcome assessment.
Development took place at the Institute of Molecular Genetics of the Russian Academy of Sciences, where a series of short peptides were designed in the 1980s and 1990s. Selank was selected from variants of tuftsin that showed resistance to plasma peptidases. Russian regulatory approval covers it as an anxiolytic agent given intranasally. Outside that market the compound is normally handled as a research chemical rather than a medicine, and no widely recognised international pharmacopoeial monograph exists. The name Selank is a coined trade designation rather than a systematic chemical name.
Enzymatic stability motivates the extra three residues at the carboxyl end. Native tuftsin is cleaved quickly by circulating aminopeptidases and carboxypeptidases, which limits its duration of action and its usefulness as a tool compound. Extending the chain with proline-rich segments is a common design tactic because proline constrains the backbone and slows proteolysis. The same Pro-Gly-Pro motif appears in other Russian-developed peptides of the era. Whether the full seven-residue chain is required for activity, or whether it acts mainly as a prodrug releasing tuftsin, remains unresolved.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its four N-terminal residues reproduce tuftsin, a tetrapeptide fragment of the immunoglobulin heavy chain, while the C-terminal Pro-Gly-Pro extension is a synthetic addition. The peptide has a molecular mass near 752 daltons and carries a net positive charge at physiological pH because of the arginine and lysine side chains. Published indexes list it under the name Selank and the sequence abbreviation TKPRPGP. Solid-phase peptide synthesis is the standard production route for research quantities.
| Property | Value | Notes |
|---|---|---|
| Principal proposed target | GABA-A receptor complex | Hypothesis derived mainly from animal pharmacology |
| Common behavioral assay | Elevated plus maze | Rodent test for anxiety-like behavior |
| Reported molecular marker | Hippocampal BDNF expression | Measured by immunoassay or mRNA quantification |
| Typical dosing route | Intranasal | Chosen to reduce first-pass metabolism |
| Reported plasma half-life | Minutes | Based on limited peptide stability data |
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, frequently abbreviated as TKPRPGP. It was designed as a structural analogue of tuftsin, a naturally occurring tetrapeptide released by enzymatic cleavage of the immunoglobulin heavy chain. The two additional proline residues at the C-terminal end extend the parent chain and change how the molecule behaves in solution. The free peptide has a calculated molecular mass of approximately 751.9 g/mol and is generally supplied as a lyophilised white to off-white powder.
Development work on the compound began in the 1980s and 1990s at the Institute of Molecular Genetics in Moscow, within the same research programme that produced the peptide Semax. Early investigators sought a tuftsin derivative with improved resistance to enzymatic breakdown and with activity in the central nervous system after peripheral administration. Most of the primary literature from this period was published in Russian, a factor that still shapes how easily the findings can be checked by outside groups.
Characterization of Selank in laboratory settings relies on standard peptide analytical techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and degradation products, while mass spectrometry confirms molecular identity through accurate mass measurement. Amino acid analysis and peptide sequencing verify the primary structure when reference material is unavailable. Because Selank is a short chain, fragmentation-based analysis produces a diagnostic ion pattern that supports confident identification.
Peptide stability depends strongly on temperature, moisture, and pH. Lyophilized Selank is generally most stable when stored cold and dry, with freezer temperatures commonly used for long-term storage. In solution, the compound is susceptible to hydrolysis and to microbial growth if it is not handled aseptically. The C-terminal proline-rich extension appears to slow enzymatic cleavage relative to tuftsin, though quantitative degradation rates vary with the matrix and the conditions tested. Published stability data specific to Selank remain sparse.
Quality assessment of Selank samples typically combines purity determination with identity confirmation and counter-ion analysis. Purity is usually reported as a percentage by chromatographic area, with values above 95 percent often quoted for research-grade material. Water content and residual solvents are checked in lyophilized batches because they affect both stability and accurate mass determination. A reported purity figure does not by itself establish that a sample is the intended sequence, so orthogonal methods are needed to rule out sequence isomers or truncation products.
Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.
Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.
Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.
=== Miscellaneous === Liquids are sometimes used in measuring devices. A thermometer often uses the thermal expansion of liquids, such as mercury, combined with their ability to flow to indicate temperature. A manometer uses the weight of the liquid to indicate air pressure. The free surface of a rotating liquid forms a circular paraboloid and can therefore be used as a telescope. These are known as liquid-mirror telescopes. They are significantly cheaper than conventional telescopes, but can only point straight upward (zenith telescope). A common choice for the liquid is mercury.
In August 2025, the United States began a military buildup in the southern Caribbean, deploying warships and military personnel. The Central Intelligence Agency (CIA) sent a team into Venezuela that began tracking Maduro's movements, using a source close to the Venezuelan president, and plans were made for the capture of Maduro months in advance. The Delta Force and other participants in the operation erected a mockup of the safe house in which Maduro was believed to be hiding, described by Trump as a "very highly guarded ... fortress". In September, the United States Southern Command began conducting military strikes on vessels in the Caribbean Sea, alleging some were trafficking drugs on behalf of Venezuela. In November 2025, Venezuelan opposition leader María Corina Machado promised to open Venezuela's oil and gas reserves during a business meeting in Miami attended by Trump, and the Trump administration engaged in secret talks with Maduro's government about its oil reserves. In December 2025, this escalated to include seizures of sanctioned oil tankers carrying Venezuelan crude. These seizures formed part of the broader blockade on sanctioned oil preceding the January 2026 operation. The US also launched covert operations in Venezuela under the directive of the CIA in late December. On 2 January 2026, Trump announced that the US military would conduct strikes inside Venezuela. In the weeks preceding the operation, Trinidad and Tobago signed an agreement with the US to allow US military access to its airports.
== Subsidiaries == Following declining earnings in 1965, HVEC reorganized into profit centers and established three wholly owned subsidiaries to diversify beyond particle accelerators. After U.S. orders for new accelerators ceased in the early 1970s, HVEC transformed into a miniconglomerate with more than ten subsidiaries, and industrial products from these units accounted for 80 percent of company revenues by 1972.
3,114km of high-pressure petroleum and gas pipelines An inland accumulation facility at Jameson Park, Gauteng (TM2), with a capacity of 180Ml A tank farm in Tarlton, Gauteng, for storage and distribution via rail and road, with a capacity of 29Ml A coastal terminal at Island View in Durban, for continuously supplying jet fuel to O.R. Tambo International Airport The Transnet pipeline network transports over 80% of refined fuel products for use in the inland market, and over 70% of the jet fuel used at O.R. Tambo International Airport. Approximately three-quarters of South Africa's fuel imports flow through Island View Precinct, which forms part of the Port of Durban. The Precinct serves as the country's main fuel storage and supply hub. Data for Transnet's pipeline fuel logistics is in the table below.
Sources: en.wikipedia.org
=== Courtship === Male courtship in P. phalangioides can be observed in four different steps: abdominal vibrations, tapping of the female's web, web jerking, and tapping the female's legs. In order to mate with the females, the males must perform courtship in a manner which will not result in the female assuming that the male is prey. Otherwise, the male would be attacked. As the males approach the females, they begin to do a series of rapid dorso-ventral vibrations with their opisthosoma. This only occurs once the females have noticed the presence of the males. The males then use the ventral portion of their tarsus to begin tapping on the web of the female. This tapping can last up to twenty minutes as the male inches closer to the female. Then, using claws on their tarsus, the males hook onto the web and perform rapid jerk movements using their legs. On average, this jerking lasts for a few minutes with each jerk lasting less than half of a second. In between sequences of jerking, the males continue to move closer to the females. The males then tap on the female's legs with their cephalothorax positioned downwards for, on average, eight minutes. At this point, receptive females will take on a specific position in which they are motionless with their opisthosoma turned horizontally and their legs extended outward. Before coupling, many of the males will use their pedipalps to cut certain parts of the web closest to the female.
The H+ gradient can be eliminated either with H+ ionophores (protonophores) such as nigericin or monensin or by inhibiting the V-ATPase that generates the H+ gradient with compounds such as bafilomycin A1 or concanamycin.
In Somaliland, the Isaaq Sultanate was established in 1750. The Isaaq Sultanate was a Somali kingdom that ruled parts of the Horn of Africa during the 18th and 19th centuries. It spanned the territories of the Isaaq clan, descendants of the Banu Hashim clan, in modern-day Somaliland and Ethiopia. The sultanate was governed by the Rer Guled branch established by the first sultan, Sultan Guled Abdi, of the Eidagale clan. According to oral tradition, prior to the Guled dynasty the Isaaq clan-family were ruled by a dynasty of the Tolje'lo branch starting from, descendants of Ahmed nicknamed Tol Je'lo, the eldest son of Sheikh Ishaaq's Harari wife. There were eight Tolje'lo rulers in total, starting with Boqor Harun (Somali: Boqor Haaruun) who ruled the Isaaq Sultanate for centuries starting from the 13th century. The last Tolje'lo ruler Garad Dhuh Barar (Somali: Dhuux Baraar) was overthrown by a coalition of Isaaq clans. The once strong Tolje'lo clan were scattered and took refuge amongst the Habr Awal with whom they still mostly live. In the late 19th century, after the Berlin Conference of 1884, European powers began the Scramble for Africa. In that year, a British protectorate was declared over part of Somalia, on the African coast opposite South Yemen. Initially, this region was under the control of the Indian Office, and so administered as part of the Indian Empire; in 1898 it was transferred to control by London.
Sources: en.wikipedia.org
Intranasal administration predominates in both animal and human research because it avoids hepatic first-pass metabolism. Injectable and intraperitoneal routes appear in animal work mainly for comparison.
Behavioral endpoints include time spent in open arms of the elevated plus maze and avoidance latencies. Biochemical endpoints include BDNF concentration, cytokine levels, and monoamine metabolite ratios in brain tissue.
Most published studies are small, originate from a limited number of laboratories, and lack independent replication. Dose-response relationships, measured brain exposure, and long-term outcomes are not well characterized.
Selank is a seven-amino-acid peptide built from the tuftsin sequence plus a Pro-Gly-Pro tail. It is produced by chemical synthesis rather than extracted from a natural source. The free peptide is usually supplied as a lyophilised powder or in an aqueous formulation.